GROVE CITY, Ohio, Oct. 6, 2025 /PRNewswire/ -- Tosoh Bioscience, Inc., a market leader in clinical diagnostics is proud to announce that it has received US FDA 510(k) clearance for its next-generation ...
Delivering CVs ≤ 1.1% (NGSP Units), the GR01 provides reproducibility and reliability — helping clinicians make confident diagnostic and therapeutic decisions in diabetes management. "The GR01 ...
Diagnostic test maker Tosoh Bioscience has received an FDA warning letter over record-keeping violations and failing to follow industry manufacturing standards at its Grove City, Ohio, location. Among ...
Separation and purification media are key products of Tosoh’s Bioscience Division and are used in the purification process of biopharmaceutical manufacturing as well as other processes. One of the ...
Tosoh Bioscience – Separation & Purification announced the grand opening of its expanded European Tosoh Bioscience headquarters in Griesheim, Germany. This significant milestone marks a new chapter in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results